ClinConnect ClinConnect Logo
Search / Trial NCT06776965

Ultra Processed Foods Consumption and Impact in Rheumatic Diseases.

Launched by HOSPICES CIVILS DE LYON · Jan 10, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Ultra Processed Food Osteoarthritis Rheumatoid Arthritis Spondyloarthritis

ClinConnect Summary

This clinical trial is investigating the impact of ultra-processed foods (UPF) on people with certain rheumatic diseases, such as rheumatoid arthritis, spondyloarthritis, and osteoarthritis. UPFs are foods that are heavily processed and often contain artificial ingredients. Researchers want to understand how eating these types of foods might be linked to the activity and severity of rheumatic diseases. They are particularly interested in whether UPF consumption can affect the immune system and gut health, which are important in these conditions.

To participate in the study, individuals must be over 18 years old and have a chronic rheumatic disease. They should also be able to complete questionnaires about their eating habits and health. Unfortunately, those who are under legal protection or have more than one rheumatic disease at the same time cannot join. If you take part, you will be asked about your diet and how it relates to your health, helping researchers learn more about the connection between diet and rheumatic diseases. This could lead to better dietary recommendations for people living with these conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 18 years
  • chronic rheumatic disease (Rheumatoid arthritis, spondyloarthritis, osteoarthritis)
  • ability to perform questionnaires
  • Exclusion Criteria:
  • Judicial protection measure
  • Refusal to participate in the study
  • Suffering from 2 rheumatic disease simultaneously

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon, , France

Patients applied

0 patients applied

Trial Officials

Maxime AUROUX, MD

Principal Investigator

Edouard Herriot Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported